Ignite Creation Date:
2025-12-24 @ 9:32 PM
Ignite Modification Date:
2025-12-30 @ 7:47 PM
Study NCT ID:
NCT00769132
Status:
COMPLETED
Last Update Posted:
2019-11-21
First Post:
2008-10-07
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study to Evaluate the Effects of Extended Release (ER) Niacin/Laropiprant, Laropiprant, ER Niacin, and Placebo on Urinary Prostanoid Metabolites in Subjects With High Cholesterol (0524A-075)(COMPLETED)
Sponsor:
Merck Sharp & Dohme LLC
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2007-08-03
Start Date Type:
ACTUAL
Primary Completion Date:
2007-10-13
Primary Completion Date Type:
ACTUAL
Completion Date:
2007-11-06
Completion Date Type:
ACTUAL
First Submit Date:
2008-10-07
First Submit QC Date:
None
Study First Post Date:
2008-10-08
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2008-10-30
Results First Submit QC Date:
None
Results First Post Date:
2008-11-27
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-11-08
Last Update Post Date:
2019-11-21
Last Update Post Date Type:
ACTUAL